Aspira Pathlab & Diagnostics Ltd Share Price

Healthcare

BSE: 540788 Small Cap ISIN: INE500C01017

As on 09 July 2026 at 00:03 IST

Stock Not Traded in BSE

Over 1 Month

85.30%

Over 6 Months

72.10%

Over 1 Year

100.34%

Over 3 Years

307.73%

Aspira Pathlab & Diagnostics Ltd Summary

Close ₹118.20

Open ₹118.50

High ₹118.50

Low ₹118.20

Volume 131

Net Turnover (in Cr) ₹0.0015

52Wk High ₹135.88

52Wk Low ₹49

52Wk High / Low

135.88

Aspira Pathlab & Diagnostics Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹121.66

EPS (TTM) 0.05

Book Value (BV) 11.88

Div. Yield -

P/E (TTM) 2,364

Price/Book Value 9.95

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio 42.40

PB Ratio 12.04

EV to Sales 3.98

PEG Ratio -0.24

ROA 12.96

ROE 16.88

Debt-Equity 0.15

Net Profit Margin 9.41

Operating Profit Margin 17.82

Aspira Pathlab & Diagnostics Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Total Revenue	22.39	13.63
Total Expenses	20.32	16.30
Profit Before Tax	2.02	-2.67
Profit After Tax	2.02	-2.67
Operating Profit After Depreciation	2.42	-2.30

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Fixed Assets	6.53	6.79
Total Non Current Assets	12.10	10.35
Total Current Assets	5.36	4.36
Total Assets	17.46	14.71
Total Shareholder's Fund	12.17	10.14

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	1.83	1.05
Net Cash Used In Investing Activities	0.12	0.14
Net Cash Used In Financing Activities	-0.99	-0.95

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	22.39	13.63	14.78	19.64	15.41
Total Expenses	20.32	16.30	14.87	15.18	14.03
Profit Before Tax	2.07	-2.67	-0.09	4.46	1.38
Profit After Tax	2.07	-2.67	-0.09	4.46	1.38
Operating Profit After Depreciation	2.42	-2.30	0.33	4.83	2.27

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	6.53	6.79	8.01	9.57	7.75
Total Non Current Assets	12.15	10.35	11.49	10.99	7.90
Total Current Assets	5.36	4.36	5.86	7.14	3.88
Total Assets	17.51	14.71	17.34	18.14	11.78
Total Shareholder's Fund	12.22	10.14	12.75	12.79	8.31

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	1.88	1.05	-0.01	2.03	5.67
Net Cash Used In Investing Activities	0.07	0.14	0.16	-0.51	-0.09
Net Cash Used In Financing Activities	-0.99	-0.95	-0.94	-1.35	-2.17

Particulars (in ₹ Cr.)	2025-06	2025-03	2024-12	2024-09	2024-06
Total Revenue	5.25	5.78	5.41	6.18	4.64
Total Expenses	4.57	4.85	4.80	4.90	4.37
Profit Before Tax	0.42	0.69	0.31	1	0.04
Profit After Tax	0.42	0.68	0.31	0.99	0.05
Operating Profit after Depreciation	0.79	1.06	0.70	1.36	0.42

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	6.52	5.12	8.09	5.25	5.78
Total Expenses	6.85	6.33	5.90	4.42	4.72
Profit Before Tax	-0.69	-1.56	1.83	0.48	0.73
Profit After Tax	-0.69	-1.56	1.84	0.47	0.72
Operating Profit after Depreciation	-0.19	-1.08	2.33	0.94	1.19

Aspira Pathlab & Diagnostics Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 118.10

S2 118

S3 117.80

Pivot 118.30

R1 118.40

R2 118.60

R3 118.70

Moving Average

20 SMA 116.55

50 SMA 83.29

100 SMA 72.01

200 SMA 68.06

Aspira Pathlab & Diagnostics Ltd Corporate Actions

No available data

AGM Date: 22 Sep 2021

Aspira Pathlab & Diagnostics Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 16, 2021 to September 22, 2021 (both days inclusive) for the purpose of 48th Annual General Meeting (AGM) of the Company to be held on September 22, 2021. Proceedings of the 48th Annual General Meeting held on September 22 2021 (As Per BSE Announcement Dated on 9/22/2021 4:46:07 AM) Voting Results Under Regulation 44(3) of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report on Voting Results of 48th Annual General Meeting Held on September 22 2021 Voting Results Under Regulation 44(3) of SEBI (LODR) Regulations 2015 In Respect of 48th Annual General Meeting Held on September 22 2021 (As Per BSE Announcement Dated on 9/24/2021 11:11:55 AM)

AGM Date: 10 Sep 2022

AGM 10/09/2022 49th Annual General Meeting scheduled to be held on September 10, 2022 Book Closure for 49th Annual General Meeting of the Company (As Per BSE Announcement Dated on 13/08/2022) Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice convening the 49th Annual General Meeting of the Company, scheduled to be held on Saturday, September 10, 2022 at 11:30 A.M. through Video Conferencing/ Other Audio Visual Means. (As Per BSE Announcement Dated on 18.08.2022) Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we enclose a summary of proceedings of the 49th Annual General Meeting of the Company held on Saturday, September 10, 2022 through Video Conferencing (VC). The meeting was commenced at 11:30 A.M. and concluded at 11:50 A.M. Kindly take the above information on your record. (As Per BSE Announcement Dated on 10.09.2022) We wish to inform you that the 49th Annual General Meeting of Aspira Pathlab & Diagnostics Limited held on Saturday, September 10, 2022 at 11:30 A.M. through Video Conference in compliance with the provisions of Companies Act, 2013 & circulars issued by Ministry of Corporate Affairs in this behalf. In this regard, please find enclosed the following: a) Scrutinizer''s Report dated September 12, 2022 pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014. b) Voting results of remote e-voting and e-voting during AGM, pursuant to regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on your records. Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 12.09.2022)

AGM Date: 26 Sep 2023

AGM 26/09/2023 Newspaper advertisement regarding Fifty Annual General Meeting of Aspira Pathlab & Diagnostics Limited to be held on Tuesday September 26, 2023 at 12.00 PM (IST) via VC/OVAM. (As Per BSE Announcement Dated on 01/09/2023) Proceedings of 50th Annual General Meeting of the Company held on Tuesday, September 26 2023 (As per BSE Announcement Dated on 26/09/2023) Appointment of Mr. Manas Mengar (DIN:10218206)as the Non-Executive and Independent Director of the Company for the period of five consecutive years. (As Per BSE Announcement Dated on 27.09.2023)

AGM Date: 27 Sep 2024

AGM 27/09/2024 51st Annual General Meeting to be held on Friday, September 27, 2024 at 12.00 P.M (IST) through Video Conferencing/Other Audio Visual Means. (As Per BSE Announcement dated on 24.08.2024) Summary Proceedings of 51st Annual General Meeting of the Company. (As Per BSE Announcement Dated on 27.09.2024)

AGM Date: 26 Sep 2025

52nd Annual General Meeting to be held on Friday, September 26, 2025 at 02.00 P.M (IST) Voting Results and Scrutinizer''s Report of 52nd Annual General Meeting. Outcome of 52nd Annual General Meeting (As Per BSE Announcement Dated on:26.09.2025)

Aspira Pathlab & Diagnostics Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Apollo Hospitals Enterprise Ltd	₹8,495.95	₹1,22,158.73
Max Healthcare Institute Ltd	₹1,008.95	₹98,195.43
Fortis Healthcare Ltd	₹988.95	₹74,661.59
Aster DM Healthcare Ltd	₹814.20	₹42,185.41
Narayana Hrudayalaya Ltd	₹1,861.80	₹38,047.89

Aspira Pathlab & Diagnostics Ltd Top Mutal Funds Invested

No data available

Aspira Pathlab & Diagnostics Ltd News

Aspira Pathlab & Diagnostics to announce Quarterly Result

On 23 May 2026

19 May 2026, 12:58 pm

Aspira Pathlab & Diagnostics to declare Quarterly Results

On 10 February 2026

05 Feb 2026, 03:37 pm

Aspira Pathlab & Diagnostics to announce Quarterly Result

On 12 November 2025

05 Nov 2025, 03:16 pm

Aspira Pathlab & Diagnostics to convene AGM

On 26 September 2025

03 Sep 2025, 09:53 am

Aspira Pathlab & Diagnostics to convene board meeting

On 12 August 2025

04 Aug 2025, 11:55 am

Aspira Pathlab & Diagnostics Ltd Stock Analysis

Annual revenue for Aspira Pathlab & Diagnostics Ltd increased by 64.30% to ₹22.39 crore in FY 2025 from ₹13.63 crore in FY 2024.
Annual Net Profit for Aspira Pathlab & Diagnostics Ltd decreased by 177.56% to ₹2.07 crore in FY 2025 from ₹-2.67 crore in FY 2024.
Promoter Shareholding in Aspira Pathlab & Diagnostics Ltd remains unchanged by 0.00% in the most recent quarter, from 18.39% in December 2025 to 18.39% in March 2026.
Aspira Pathlab & Diagnostics Ltd delivered a 1-year return of 100.34% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Aspira Pathlab & Diagnostics Ltd share price moved down by 100.00% from its previous close of INR ₹118.20. The latest Aspira Pathlab & Diagnostics Ltd share price is INR ₹0.
Aspira Pathlab & Diagnostics Ltd share price today has been at a low of 118.20 and a high of 118.50. Over the past 52 weeks, the Aspira Pathlab & Diagnostics Ltd share price has seen a low of 49 and a high of 135.88.